We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
+0.44%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90.7B
AUM Growth
–
Cap. Flow
+$94.6B
Cap. Flow
% of AUM
104.38%
Top 10 Holdings %
Top 10 Hldgs %
13.37%
Holding
1,748
New
1,748
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Microsoft
MSFT
|
+$1.39B |
| 4 |
Autodesk
ADSK
|
+$1.2B |
| 5 |
NXP Semiconductors
NXPI
|
+$1.19B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.15% |
| 2 | Healthcare | 15.73% |
| 3 | Industrials | 13.82% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Utilities | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Omega Healthcare
OHI
$14.1B
| $30.4M | 0.03% |
+1,013,745
| New | +$34.9M |
|
427
Labcorp
LH
$26.1B
| $30.3M | 0.03% |
+125,245
| New | +$31.6M |
|
428
Alexandria Real Estate Equities
ARE
$8.31B
| $30.2M | 0.03% |
+158,115
| New | +$31.5M |
|
429
ADC Therapeutics
ADCT
$132M
| $30.2M | 0.03% |
+1,111,901
| New | +$28.5M |
|
|
RERE
430
ATRenew
RERE
$1.03B
| $30.1M | 0.03% |
+3,003,193
| New | +$33.9M |
|
431
Annexon
ANNX
$881M
| $30.1M | 0.03% |
+1,617,234
| New | +$32.8M |
|
432
HCA Healthcare
HCA
$87.9B
| $29.9M | 0.03% |
+123,180
| New | +$30.1M |
|
433
Becton Dickinson
BDX
$49.8B
| $29.5M | 0.03% |
+123,016
| New | +$30.2M |
|
434
Upstart Holdings
UPST
$2.87B
| $29.4M | 0.03% |
+92,851
| New | +$18.3M |
|
435
Air Products & Chemicals
APD
$67.8B
| $29.3M | 0.03% |
+114,366
| New | +$31.6M |
|
436
VEON
VEON
$3.93B
| $28.8M | 0.03% |
+553,823
| New | +$26.6M |
|
437
State Street
STT
$52.1B
| $28.8M | 0.03% |
+339,958
| New | +$29.6M |
|
438
General Motors
GM
$76.2B
| $28.6M | 0.03% |
+542,375
| New | +$28.8M |
|
439
Ashland
ASH
$3.41B
| $28.5M | 0.03% |
+320,344
| New | +$28.1M |
|
440
EOG Resources
EOG
$74.5B
| $28M | 0.03% |
+348,552
| New | +$25.4M |
|
441
Medifast
MED
$131M
| $27.9M | 0.03% |
+145,020
| New | +$35.7M |
|
442
Nurix Therapeutics
NRIX
$2.79B
| $27.8M | 0.03% |
+927,550
| New | +$28.6M |
|
443
Yum! Brands
YUM
$41.5B
| $27.7M | 0.03% |
+226,315
| New | +$28.7M |
|
444
Progressive
PGR
$122B
| $27.6M | 0.03% |
+305,448
| New | +$29.1M |
|
445
T. Rowe Price
TROW
$23.5B
| $27.4M | 0.03% |
+139,460
| New | +$29.4M |
|
|
NVRO
446
DELISTED
NEVRO CORP.
NVRO
| $27.3M | 0.03% |
+234,378
| New | +$30.7M |
|
447
Ball Corp
BALL
$16.5B
| $27.3M | 0.03% |
+302,971
| New | +$26.9M |
|
448
Marathon Petroleum
MPC
$98.6B
| $27.2M | 0.03% |
+440,654
| New | +$25.3M |
|
449
SLB Ltd
SLB
$77.5B
| $27.2M | 0.03% |
+917,818
| New | +$26.3M |
|
450
Ametek
AME
$58.8B
| $27.1M | 0.03% |
+218,892
| New | +$29.4M |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q3 2021 Portfolio in Review
Q3 2021 is the first quarter with a 13F filing on record for Pictet Asset Management (Switzerland), which disclosed 1,748 positions worth $90.7B. Its ten largest holdings account for 13% of the portfolio.
Its largest position is Thermo Fisher Scientific: 3,054,760 shares worth $1.75B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q3 2021 buy was Thermo Fisher Scientific: 3,054,760 shares worth $1.75B.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 13% of its $90.7B portfolio in Q3 2021.
- Pictet Asset Management (Switzerland) disclosed 1,748 positions in Q3 2021, its first 13F filing on record.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2021, filed 12 Nov 2021.